By: Julie Coleman
CNBC's Jim Cramer told investors to avoid several cohorts that don't usually include stocks set up for long-term gains in any market condition.


Julie Coleman is an Associate Reporter at CNBC, primarily contributing to 'Mad Money' with Jim Cramer. She focuses on topics such as alternative investments, asset management, and investment strategies, drawing on her background in English and film from the University of Pennsylvania. Julie's work has been featured in various outlets, including NBC10 Philadelphia, NBC 7 San Diego, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Julie Coleman's coverage mainly focuses on investment analysis, expert commentary, and themes related to healthcare & pharmaceuticals, sales & marketing, and big tech. She may be interested in pitches that offer insights from financial experts or industry insiders regarding stock market trends, CEO strategies, or technology advancements within the healthcare and pharmaceutical sectors.
Given the emphasis on investment analysis in her articles, she might respond well to pitches providing unique perspectives on stock market movements, impact of CEO decisions on company performance and investor sentiments. Additionally, she could be open to contributions discussing emerging technologies influencing sales & marketing tactics within these industries.
It's worth noting that Julie doesn't have a specific geographic focus but appears to cover international companies and their activities without being restricted by location.
This information evolves through artificial intelligence and human feedback. Improve this profile .